Immunolabeling for glial fibrillary acidic protein (GFAP) is considered supportive of the diagnosis of astrocytoma whereas immunolabeling for CNPase is considered supportive of the diagnosis of oligodendroglioma (78). Here, GFAP is linked to oligodendroglioma.